Principal Financial Group
ALDR

Principal Financial Group’s Alder Biopharmaceuticals ALDR Stock Holding History

Principal Financial Group’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-23,572
Closed -$445K – 2336
2019
Q3 		$445K Buy
23,572
+11,311
+92% +$129K ﹤0.01% 1970
2019
Q2 		$144K Buy
12,261
+1,543
+14% +$18.7K ﹤0.01% 2167
2019
Q1 		$146K Buy
+10,718
New +$139K ﹤0.01% 2141
2018
Q4 		– Sell
-20,904
Closed -$348K – 2362
2018
Q3 		$348K Buy
+20,904
New +$378K ﹤0.01% 2044
2018
Q2 		– Sell
-12,170
Closed -$155K – 2328
2018
Q1 		$155K Buy
12,170
+1,090
+10% +$15.8K ﹤0.01% 2132
2017
Q4 		$127K Buy
+11,080
New +$124K ﹤0.01% 2171
2016
Q4 		– Sell
-8,336
Closed -$273K – 2262
2016
Q3 		$273K Buy
8,336
+92
+1% +$2.8K ﹤0.01% 1967
2016
Q2 		$206K Buy
+8,244
New +$223K ﹤0.01% 2021

Principal Financial Group's ALDR Position: Q4 2019 in Review

Principal Financial Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 23,572 shares — an estimated $445K sold.

Principal Financial Group first reported a position in ALDR in Q2 2016 and held it in 8 quarters. The position peaked at $445K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Principal Financial Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Principal Financial Group sold 23,572 Alder Biopharmaceuticals shares in Q4 2019, an estimated $445K.
  • Principal Financial Group first reported a position in Alder Biopharmaceuticals in Q2 2016 and held it in 8 quarters.
  • Principal Financial Group's Alder Biopharmaceuticals position peaked at $445K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Principal Financial Group's 13F filing for Q4 2019, filed 5 Feb 2020.